Reference
Growdon ME, et al. Potential Medicare Savings From Generic Substitution and Therapeutic Interchange of ACE Inhibitors and Angiotensin-II-Receptor Blockers. JAMA Internal Medicine : 5 Aug 2019. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2019.3107
Rights and permissions
About this article
Cite this article
Substantial savings from generic/therapeutic substitution in the US. PharmacoEcon Outcomes News 835, 31 (2019). https://doi.org/10.1007/s40274-019-6168-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6168-z